Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
March 18, 2003
Persistent Müllerian duct syndrome
Helena M Dekker, Igle J de Jong, Joyce Sanders, et al.
Cancer
|
June 6, 2006
Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration
Henk Kramer, Joyce Sanders, Wendy J Post, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 25, 2020
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes
Dinja T Kruger, Mark Opdam, Joyce Sanders, et al.
The Journal of Urology
|
December 3, 2014
Classic and nonclassic HLA class I expression in penile cancer and relation to HPV status and clinical outcome
Rosa S Djajadiningrat, Simon Horenblas, Daniëlle A M Heideman, et al.
British Journal of Cancer
|
October 6, 2018
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences
Dinja T Kruger, Karin J Beelen, Mark Opdam, et al.
Neuroendocrinology
|
October 25, 2014
Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?
Marie-Louise F van Velthuysen, Emilie J Groen, Joyce Sanders, et al.
BMC Cancer
|
July 26, 2018
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
Karin Beelen, Mark Opdam, Tesa Severson, et al.
Clinical Nuclear Medicine
|
August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer
Jurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 19, 2022
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
Maria J Disselhorst, Yoni Lubeck, Vincent van der Noort, et al.
Oncotarget
|
April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
Suzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
March 18, 2003
Persistent Müllerian duct syndrome
Helena M Dekker, Igle J de Jong, Joyce Sanders, et al.
Cancer
|
June 6, 2006
Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration
Henk Kramer, Joyce Sanders, Wendy J Post, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 25, 2020
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes
Dinja T Kruger, Mark Opdam, Joyce Sanders, et al.
The Journal of Urology
|
December 3, 2014
Classic and nonclassic HLA class I expression in penile cancer and relation to HPV status and clinical outcome
Rosa S Djajadiningrat, Simon Horenblas, Daniëlle A M Heideman, et al.
British Journal of Cancer
|
October 6, 2018
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences
Dinja T Kruger, Karin J Beelen, Mark Opdam, et al.
Neuroendocrinology
|
October 25, 2014
Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?
Marie-Louise F van Velthuysen, Emilie J Groen, Joyce Sanders, et al.
BMC Cancer
|
July 26, 2018
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
Karin Beelen, Mark Opdam, Tesa Severson, et al.
Clinical Nuclear Medicine
|
August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer
Jurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 19, 2022
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
Maria J Disselhorst, Yoni Lubeck, Vincent van der Noort, et al.
Oncotarget
|
April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
Suzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
Page
of 9